PT  - JOURNAL ARTICLE
AU  - Denaxas, Spiros
AU  - Shah, Anoop D.
AU  - Mateen, Bilal A.
AU  - Kuan, Valerie
AU  - Quint, Jennifer K.
AU  - Fitzpatrick, Natalie
AU  - Torralbo, Ana
AU  - Fatemifar, Ghazaleh
AU  - Hemingway, Harry
TI  - A semi-supervised approach for rapidly creating clinical biomarker phenotypes in the UK Biobank using different primary care EHR and clinical terminology systems
AID  - 10.1101/2020.05.14.20101626
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.14.20101626
4099  - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101626.short
4100  - http://medrxiv.org/content/early/2020/05/19/2020.05.14.20101626.full
AB  - Objectives The UK Biobank (UKB) is making primary care Electronic Health Records (EHR) for 500,000 participants available for COVID-19-related research. Data are extracted from four sources, recorded using five clinical terminologies and stored in different schemas. The aims of our research were to: a) develop a semi-supervised approach for bootstrapping EHR phenotyping algorithms in UKB EHR, and b) to evaluate our approach by implementing and evaluating phenotypes for 31 common biomarkers.Materials and Methods We describe an algorithmic approach to phenotyping biomarkers in primary care EHR involving a) bootstrapping definitions using existing phenotypes, b) excluding generic, rare or semantically distant terms, c) forward-mapping terminology terms, d) expert review, and e) data extraction. We evaluated the phenotypes by assessing the ability to reproduce known epidemiological associations with all-cause mortality using Cox proportional hazards models.Results We created and evaluated phenotyping algorithms for 31 biomarkers many of which are directly related to COVID–19 complications e.g. diabetes, cardiovascular disease, respiratory disease. Our algorithm identified 1651 Read v2 and Clinical Terms Version 3 terms and automatically excluded 1228 terms. Clinical review excluded 103 terms and included 44 terms, resulting in 364 terms for data extraction (sensitivity 0.89, specificity 0.92). We extracted 38,190,682 events and identified 220,978 participants with at least one biomarker measured.Discussion and conclusion Bootstrapping phenotyping algorithms from similar EHR can potentially address pre-existing methodological concerns that undermine the outputs of biomarker discovery pipelines and provide research-quality phenotyping algorithms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is part of the BigData@Heart programme that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 116074. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA. This work was supported by Health Data Research UK, which receives its funding from Health Data Research UK Ltd (NIWA1) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and the Wellcome Trust. This article represents independent research part funded by the National Institute for Health Research Biomedical Research Centre at University College London Hospitals. HH is a National Institute for Health Research Senior Investigator. ADS is a THIS Institute postdoctoral fellow. VK is supported by the Wellcome Trust (WT 110284/Z/15/Z). SD is supported by an Alan Turing Fellowship. G.F is funded by the American Heart Association Institutional Data Fellowship Program (AHA Award 17IF3389000).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Read v2 to CTV3 mapping file is available from the NHS TRUD service online https://isd.digital.nhs.uk/trud3/user/guest/group/0/home. UKB data can be obtained following approval by applying to the UKB Access Management Committee https://bbams.ndph.ox.ac.uk/ams/. Data in this project was analyzed under protocol ref. 9922 which has been approved by the UKB.